Literature DB >> 26052916

High-resolution HLA matching in unrelated donor transplantation in Switzerland: differential impact of class I and class II mismatches may reflect selection of nonimmunogenic or weakly immunogenic DRB1/DQB1 disparities.

J R Passweg1, U Schanz2, Y Chalandon3, T Güngör4, H Baldomero5, D Heim1, G Nair2, M Medinger1, S Masouridi-Levrat3, G N de Faveri6, J-M Tiercy7.   

Abstract

Unrelated donor searches in Switzerland require high-resolution HLA typing for HLA-A/B/C/DRB1/DRB3,4/DQB1 loci. We evaluated this strategy accepting donors with ⩾9/10 match. Of 802 unrelated donor transplants in 2000-2013, 570 were 10/10 matched, 31 were DRB3/4 mismatched, 261 were single-allele mismatched and 13 had 2 allele mismatches. Of the 261 single-allele disparities, 60 concerned HLA-A/-B, 55 HLA-C and 73 HLA-DRB1/-DQB1 loci. Transplants were reduced intensity conditioning (289, 36%), marrow (187, 23%), EBMT risk score was low in 39, intermediate I in 331, intermediate II in 333 and high in 99 patients. Five-year survival was 48±4%. HLA affected survival in the multivariate model adjusted for risk score. HLA-A/-B and HLA-C mismatches had twice the mortality risks, whereas HLA-DRB1/-DQB1 mismatches were similar to matched transplants. HLA-DRB3/4 mismatches were associated with a nonsignificant increased mortality risk. HLA-DRB3/4 mismatches had higher graft-versus-host disease and transplant-related mortality risks and lower relapse rates compared with matched transplants. We show significant effects of HLA class I, but not HLA class II, mismatches. The lack of impact of DRB1 disparities may be related to the lower immunogenicity of the DRB1*11:01/11:04 and DRB1*14:01/14:54 mismatches, representing 46% of DRB1 incompatibilities. These results support a matching algorithm that prioritizes mismatches considered as more permissive.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26052916     DOI: 10.1038/bmt.2015.129

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


  31 in total

1.  Selection of unrelated donors for bone marrow transplantation is improved by HLA class II genotyping with oligonucleotide hybridization.

Authors:  J M Tiercy; C Morel; A C Freidel; F Zwahlen; L Gebuhrer; H Bétuel; M Jeannet; B Mach
Journal:  Proc Natl Acad Sci U S A       Date:  1991-08-15       Impact factor: 11.205

2.  The set of naturally processed peptides displayed by DR molecules is tuned by polymorphism of residue 86.

Authors:  S Demotz; C Barbey; G Corradin; A Amoroso; A Lanzavecchia
Journal:  Eur J Immunol       Date:  1993-02       Impact factor: 5.532

3.  Impact of high-resolution matching in allogeneic unrelated donor stem cell transplantation in Switzerland.

Authors:  Y Chalandon; J-M Tiercy; U Schanz; T Gungor; R Seger; J Halter; C Helg; B Chapuis; A Gratwohl; A Tichelli; G Nicoloso de Faveri; E Roosnek; J R Passweg
Journal:  Bone Marrow Transplant       Date:  2006-05       Impact factor: 5.483

Review 4.  The impact of HLA genotyping on survival following unrelated donor haematopoietic stem cell transplantation.

Authors:  Bronwen E Shaw; Rafael Arguello; Christian A Garcia-Sepulveda; J Alejandro Madrigal
Journal:  Br J Haematol       Date:  2010-06-15       Impact factor: 6.998

5.  High-resolution HLA matching in hematopoietic stem cell transplantation: a retrospective collaborative analysis.

Authors:  Daniel Fürst; Carlheinz Müller; Vladan Vucinic; Donald Bunjes; Wolfgang Herr; Martin Gramatzki; Rainer Schwerdtfeger; Renate Arnold; Hermann Einsele; Gerald Wulf; Michael Pfreundschuh; Bertram Glass; Hubert Schrezenmeier; Klaus Schwarz; Joannis Mytilineos
Journal:  Blood       Date:  2013-09-17       Impact factor: 22.113

Review 6.  Optimal HLA matching in hematopoietic cell transplantation.

Authors:  Effie W Petersdorf
Journal:  Curr Opin Immunol       Date:  2008-08-08       Impact factor: 7.486

7.  Impact of HLA class I and class II high-resolution matching on outcomes of unrelated donor bone marrow transplantation: HLA-C mismatching is associated with a strong adverse effect on transplantation outcome.

Authors:  Neal Flomenberg; Lee Ann Baxter-Lowe; Dennis Confer; Marcelo Fernandez-Vina; Alexandra Filipovich; Mary Horowitz; Carolyn Hurley; Craig Kollman; Claudio Anasetti; Harriet Noreen; Ann Begovich; William Hildebrand; Effie Petersdorf; Barbara Schmeckpeper; Michelle Setterholm; Elizabeth Trachtenberg; Thomas Williams; Edmond Yunis; Daniel Weisdorf
Journal:  Blood       Date:  2004-06-10       Impact factor: 22.113

8.  Multiple mismatches at the low expression HLA loci DP, DQ, and DRB3/4/5 associate with adverse outcomes in hematopoietic stem cell transplantation.

Authors:  Marcelo A Fernández-Viña; John P Klein; Michael Haagenson; Stephen R Spellman; Claudio Anasetti; Harriet Noreen; Lee Ann Baxter-Lowe; Pedro Cano; Neal Flomenberg; Dennis L Confer; Mary M Horowitz; Machteld Oudshoorn; Effie W Petersdorf; Michelle Setterholm; Richard Champlin; Stephanie J Lee; Marcos de Lima
Journal:  Blood       Date:  2013-04-17       Impact factor: 22.113

9.  Effect of matching of class I HLA alleles on clinical outcome after transplantation of hematopoietic stem cells from an unrelated donor. Japan Marrow Donor Program.

Authors:  T Sasazuki; T Juji; Y Morishima; N Kinukawa; H Kashiwabara; H Inoko; T Yoshida; A Kimura; T Akaza; N Kamikawaji; Y Kodera; F Takaku
Journal:  N Engl J Med       Date:  1998-10-22       Impact factor: 91.245

10.  High-resolution donor-recipient HLA matching contributes to the success of unrelated donor marrow transplantation.

Authors:  Stephanie J Lee; John Klein; Michael Haagenson; Lee Ann Baxter-Lowe; Dennis L Confer; Mary Eapen; Marcelo Fernandez-Vina; Neal Flomenberg; Mary Horowitz; Carolyn K Hurley; Harriet Noreen; Machteld Oudshoorn; Effie Petersdorf; Michelle Setterholm; Stephen Spellman; Daniel Weisdorf; Thomas M Williams; Claudio Anasetti
Journal:  Blood       Date:  2007-09-04       Impact factor: 22.113

View more
  4 in total

Review 1.  How to select the best available related or unrelated donor of hematopoietic stem cells?

Authors:  Jean-Marie Tiercy
Journal:  Haematologica       Date:  2016-05-31       Impact factor: 9.941

2.  In silico prediction of nonpermissive HLA-DPB1 mismatches in unrelated HCT by functional distance.

Authors:  Esteban Arrieta-Bolaños; Pietro Crivello; Bronwen E Shaw; Kwang Woo Ahn; Hai-Lin Wang; Michael R Verneris; Katharine C Hsu; Joseph Pidala; Stephanie J Lee; Katharina Fleischhauer; Stephen R Spellman
Journal:  Blood Adv       Date:  2018-07-24

3.  Exome chip analyses identify genes affecting mortality after HLA-matched unrelated-donor blood and marrow transplantation.

Authors:  Qianqian Zhu; Li Yan; Qian Liu; Chi Zhang; Lei Wei; Qiang Hu; Leah Preus; Alyssa I Clay-Gilmour; Kenan Onel; Daniel O Stram; Loreall Pooler; Xin Sheng; Christopher A Haiman; Xiaochun Zhu; Stephen R Spellman; Marcelo Pasquini; Philip L McCarthy; Song Liu; Theresa Hahn; Lara E Sucheston-Campbell
Journal:  Blood       Date:  2018-04-02       Impact factor: 25.476

4.  A comparison of post-transplantation cyclophosphamide versus antithymocyte-globulin in patients with hematological malignancies undergoing HLA-matched unrelated donor transplantation.

Authors:  Myung-Won Lee; Sang Hoon Yeon; Won-Hyoung Seo; Hyewon Ryu; Hyo-Jin Lee; Hwan-Jung Yun; Deog-Yeon Jo; Ik-Chan Song
Journal:  Medicine (Baltimore)       Date:  2020-08-21       Impact factor: 1.889

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.